Need Support?
Reference laboratory billing carries a complexity no single-specialty lab faces: thousands of test codes, constant referred specimens, and Medicare rules built around the referring-lab-to-reference-lab relationship. One mismatched CLIA number or missed date-of-service exception can silently deny entire claim batches. Generalist billing companies simply aren’t built for this test menu and referral volume and the revenue loss compounds until an audit exposes it.
Modifier 90 Referral Billing Errors
Date-of-Service Exception Miscoding
Anti-Markup Rule Violations on Purchased Testing
Multi-Site CLIA Mismatch Errors
Panel Unbundling Across a Massive Test Menu
Reference laboratory billing isn’t organized around a single test menu; it’s built on billing relationships and regulatory mechanics that apply regardless of specialty. Our AAPC and AHIMA certified coders know the referral billing rules, date-of-service exceptions, and compliance requirements governing every reference lab billing category.
Billing for tests referred from another laboratory and performed by your reference lab, or billing on behalf of a referring laboratory for tests your lab performed, using the modifier 90 referral billing structure Medicare requires for laboratory-to-laboratory referrals.
Both the referring and reference laboratory's CLIA numbers must appear on the same claim, and referred and self-performed tests can never be combined on a single paper claim --- getting either wrong causes the claim to return as unprocessable rather than simply denying.
Billing molecular pathology tests, gene sequencing procedures, and advanced diagnostic laboratory tests using the correct date of service, either the specimen collection date or the test performance date, depending on whether the hospital outpatient DOS exception applies.
The DOS exception applies only when specific conditions are met, including that the specimen came from a hospital outpatient and the result didn't guide treatment during that outpatient encounter --- misapplying it routes the claim to the wrong payer and risks losing reimbursement your lab was entitled to bill directly.
Billing purchased or referred technical and professional component diagnostic services in a way that complies with Medicare's anti-markup provisions, which cap the billed amount at the lower of the billing entity's actual charge or the performing lab's own fee schedule amount.
Marking up a purchased diagnostic test above what the anti-markup rule allows is a compliance violation, not just a pricing choice --- reference labs that bill on behalf of ordering physicians need this checked on every purchased test claim.
Billing accurately across multiple laboratory locations, specialty testing sites, and CLIA certificates that a single reference lab organization may operate, ensuring each claim reflects the CLIA number of the site that actually performed the test.
A test billed under the wrong site's CLIA number is a routine, entirely preventable rejection --- at reference lab volumes, even a small error rate in CLIA assignment compounds into a meaningful revenue gap.
Coding across a test menu that can span thousands of active CPT codes, ensuring panel codes and their individual component tests are billed according to current National Correct Coding Initiative edits rather than billed separately when a panel code applies.
The sheer size of a reference lab's test menu makes NCCI edit management dramatically more complex than for a single-specialty lab --- outdated edit tables are one of the most common, and most costly, gaps in reference lab billing systems.
Managing the distinction between billing an ordering physician or client directly for testing services versus billing the patient's insurance, including the compliance controls each billing pathway requires.
Client-billed accounts still carry compliance obligations around accurate charge documentation --- treating a client account as exempt from standard billing controls is a common and avoidable exposure.
Billing for the broad menu of specialty and esoteric send-out testing that defines a reference laboratory's business, spanning molecular, genetic, endocrine, toxicology, and specialized chemistry testing referred from physician offices, hospitals, and other laboratories.
Medical necessity documentation for send-out testing often originates with an ordering physician outside your organization's direct control --- building verification checkpoints into intake is essential at the volume reference labs typically operate.
Meeting the private payer rate and volume data reporting requirements under the Protecting Access to Medicare Act, which typically apply in full to reference laboratories given their revenue mix and Medicare billing volume as an applicable laboratory.
Reference labs are among the entities most likely to meet the applicable laboratory threshold under PAMA --- inaccurate or incomplete reporting carries civil monetary penalty exposure that smaller specialty labs may never encounter.
TransLabs’ specialized RCM services are built exclusively for labs, addressing the unique challenges that generalist billers miss. We provide end-to-end revenue cycle solutions designed specifically to turn laboratory complexity into profitability.
Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.
Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.
Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.
TransLabs provides expert RCM services to clinical laboratories in all 50 states, delivering the same exceptional results whether you’re a community hospital lab or a large reference facility. We bring specialized lab billing expertise to facilities nationwide, combining remote efficiency with hands-on partnership.
Independent laboratories must append modifier 90 to every referred laboratory service, with both the referring and reference laboratory's CLIA numbers reported on the same claim. A referred service claim missing this information returns as unprocessable rather than simply denying. TransLabs validates this data on every referral claim before submission.
Medicare's general rule ties the date of service to specimen collection, but exceptions exist for molecular pathology tests and advanced diagnostic laboratory tests meeting specific hospital-outpatient criteria, allowing the reference lab to bill Medicare directly rather than seeking payment from the hospital. TransLabs evaluates every eligible test against these criteria before submission.
When a reference lab bills for a purchased or referred diagnostic test on behalf of an ordering entity, the billed amount is capped at the lower of the billing entity's net charge or the performing supplier's fee schedule amount. TransLabs checks purchased testing claims against this cap to prevent compliance exposure.
Referred and self-performed laboratory services cannot be combined on the same paper claim, and services referred to more than one reference laboratory require a separate claim for each. TransLabs structures claim submission to meet this requirement automatically.
Each laboratory location and specialty testing site operates under its own CLIA certificate, and claims must reflect the CLIA number of the site that actually performed the test. TransLabs maintains a current CLIA registry across all of your lab's locations to prevent site-mismatch rejections.
Reference laboratories are among the entities most likely to meet the applicable laboratory definition under the Protecting Access to Medicare Act, triggering mandatory private payer rate and volume data reporting during designated collection periods. TransLabs tracks your reporting obligations and supports accurate, on-time submission.
With a test menu spanning thousands of active codes, reference labs face far more NCCI edit combinations to track than a single-specialty lab. TransLabs maintains current edit tables across your full test catalog and validates claims before submission to prevent bundling-related denials.
Most billing companies are built around a single specialty’s test menu; not structured for referral billing, multi-site CLIA coordination, and thousands of active codes at once. TransLabs was built for laboratory billing exclusively, and our reference lab team is built for this exact scale: no divided attention, no generalist assumptions.
Referral billing is the focus, not an afterthought; modifier 90, DOS exception logic, and anti-markup compliance.
We treat modifier 90 billing and multi-site CLIA coordination as a core specialty; catching errors before referred claims return.
Dedicated billing specialist assigned to your laboratory
Complimentary 12-month claims audit across Medicare, Medicaid, and commercial payers
Uncover your top 3 revenue leaks (modifier 90 errors, DOS miscoding, CLIA mismatches)
Custom strategy tailored to your test menu and LIS/billing software
Live in 24 hours with no contracts and no upfront fees
Pay only a percentage of what we collect for you
Medicare generally ties a lab test’s date of service to when the specimen was collected, but an exception allows certain molecular pathology and advanced diagnostic tests to use the test performance date instead, when specific hospital-outpatient conditions are met. Getting this right determines whether your lab bills Medicare directly or has to seek payment from the hospital instead.